Literature DB >> 30908279

Immune Checkpoint Inhibitors in Uveal and Conjunctival Melanoma.

Annemijn P A Wierenga, Jinfeng Cao, Gregorius P M Luyten, Martine J Jager.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30908279     DOI: 10.1097/IIO.0000000000000263

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  9 in total

1.  Prognostic significance of PD-1/PD-L1 expression in uveal melanoma: correlation with tumor-infiltrating lymphocytes and clinicopathological parameters.

Authors:  Lata Singh; Mithalesh Kumar Singh; Maria Cristina Kenney; Martine J Jager; Moshahid Alam Rizvi; Rachna Meel; Neiwete Lomi; Sameer Bakhshi; Seema Sen; Seema Kashyap
Journal:  Cancer Immunol Immunother       Date:  2020-11-02       Impact factor: 6.968

Review 2.  Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies.

Authors:  Anastasia Gkiala; Sotiria Palioura
Journal:  Clin Ophthalmol       Date:  2020-10-09

3.  Clinical Update on Checkpoint Inhibitor Therapy for Conjunctival and Eyelid Melanoma.

Authors:  Jonathan E Lu; Jessica R Chang; Jesse L Berry; Gino K In; Sandy Zhang-Nunes
Journal:  Int Ophthalmol Clin       Date:  2020

4.  Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time.

Authors:  Christine D M Roelofsen; Annemijn P A Wierenga; Sjoerd van Duinen; Robert M Verdijk; Jaco Bleeker; Marina Marinkovic; Gregorius P M Luyten; Martine J Jager
Journal:  Ocul Oncol Pathol       Date:  2020-12-15

5.  Structural Protein Analysis of Driver Gene Mutations in Conjunctival Melanoma.

Authors:  Mak B Djulbegovic; Vladimir N Uversky; J William Harbour; Anat Galor; Carol L Karp
Journal:  Genes (Basel)       Date:  2021-10-15       Impact factor: 4.096

6.  Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment.

Authors:  Gülçin Gezgin; Marten Visser; Dina Ruano; Saskia J Santegoets; Noel F C C de Miranda; Pieter A van der Velden; Gregorius P M Luyten; Sjoerd H van der Burg; Els M Verdegaal; Martine J Jager
Journal:  Ophthalmol Sci       Date:  2022-03-01

7.  Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis.

Authors:  Hui Pan; Linna Lu; Junqi Cui; Yuan Yang; Zhaoyang Wang; Xianqun Fan
Journal:  Aging (Albany NY)       Date:  2020-01-18       Impact factor: 5.682

Review 8.  Iris Colour and the Risk of Developing Uveal Melanoma.

Authors:  Laurien E Houtzagers; Annemijn P A Wierenga; Aleid A M Ruys; Gregorius P M Luyten; Martine J Jager
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

9.  Integrative Analysis Identifies Multi-Omics Signatures That Drive Molecular Classification of Uveal Melanoma.

Authors:  Qianxing Mo; Lixin Wan; Michael J Schell; Heather Jim; Shelley S Tworoger; Guang Peng
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.